BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9401367)

  • 21. Strategies of Pseudomonas aeruginosa to colonize and to persist in the cystic fibrosis lung.
    Kubesch P; Lingner M; Grothues D; Wehsling M; Tümmler B
    Scand J Gastroenterol Suppl; 1988; 143():77-80. PubMed ID: 3133755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenic mechanisms of chronic Pseudomonas aeruginosa infections in cystic fibrosis patients.
    Høiby N; Döring G; Schiøtz PO
    Antibiot Chemother (1971); 1987; 39():60-76. PubMed ID: 3118792
    [No Abstract]   [Full Text] [Related]  

  • 23. Modulation of macrophage function for defence of the lung against Pseudomonas aeruginosa.
    Speert DP; Wong SY; Macdonald M; Sargeant R
    Behring Inst Mitt; 1997 Feb; (98):274-82. PubMed ID: 9382751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of specific immune response in early P. aeruginosa infection in cystic fibrosis patients.
    Dolce D; Cariani L; Campana S; Ravenni N; Mergni G; Biffi A; Colombo C; Gagliardini R; Cirilli N; Manso E; Padoan R; Soncini E; Forte FR; D'Aprile A; Ratclif L; Amboni M; Casciaro R; Minicucci L; Borio T; Cosimi A; Vieni G; Zinnarello C; Fiscarelli E; Collura M; Pensabene T; Braggion C; Döring G; Taccetti G
    J Cyst Fibros; 2014 Jan; 13(1):116-7. PubMed ID: 24022018
    [No Abstract]   [Full Text] [Related]  

  • 25. Viral-Bacterial Co-infections in the Cystic Fibrosis Respiratory Tract.
    Kiedrowski MR; Bomberger JM
    Front Immunol; 2018; 9():3067. PubMed ID: 30619379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunology of Pseudomonas aeruginosa infection in cystic fibrosis.
    Høiby N; Pedersen SS; Jensen ET; Pressler T; Shand GH; Kharazmi A; Döring G
    Acta Univ Carol Med (Praha); 1990; 36(1-4):16-21. PubMed ID: 2130683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudomonas aeruginosa infection and humoral antibody response of patients with cystic fibrosis.
    Neter E
    J Infect Dis; 1974 Nov; 130 Suppl(0):S132-3. PubMed ID: 4213765
    [No Abstract]   [Full Text] [Related]  

  • 28. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey.
    Hoiby N
    Acta Pathol Microbiol Scand Suppl; 1977; (262):1-96. PubMed ID: 411327
    [No Abstract]   [Full Text] [Related]  

  • 29. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
    Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
    J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgG subclasses and chronic bacterial infection. Subclass antibodies and the clinical course of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
    Pressler T
    APMIS Suppl; 1996; 66():1-41. PubMed ID: 8972694
    [No Abstract]   [Full Text] [Related]  

  • 31. Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum.
    Schiller NL; Millard RL
    Pediatr Res; 1983 Sep; 17(9):747-52. PubMed ID: 6413945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylaxis and therapy of Pseudomonas aeruginosa infection in cystic fibrosis and immunocompromised patients.
    Lang AB; Horn MP; Imboden MA; Zuercher AW
    Vaccine; 2004 Dec; 22 Suppl 1():S44-8. PubMed ID: 15576201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tracking the immunopathological response to Pseudomonas aeruginosa during respiratory infections.
    Cigana C; Lorè NI; Riva C; De Fino I; Spagnuolo L; Sipione B; Rossi G; Nonis A; Cabrini G; Bragonzi A
    Sci Rep; 2016 Feb; 6():21465. PubMed ID: 26883959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 17β-Estradiol Dysregulates Innate Immune Responses to Pseudomonas aeruginosa Respiratory Infection and Is Modulated by Estrogen Receptor Antagonism.
    Abid S; Xie S; Bose M; Shaul PW; Terada LS; Brody SL; Thomas PJ; Katzenellenbogen JA; Kim SH; Greenberg DE; Jain R
    Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial adaptation and pathogenesis.
    Govan JR; Harris GS
    Microbiol Sci; 1986 Oct; 3(10):302-8. PubMed ID: 3155268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum IgA antibodies against Pseudomonas aeruginosa in cystic fibrosis.
    Brett MM; Ghoneim AT; Littlewood JM
    Arch Dis Child; 1990 Mar; 65(3):259-63. PubMed ID: 2110441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.
    Fick RB; Naegel GP; Squier SU; Wood RE; Gee JB; Reynolds HY
    J Clin Invest; 1984 Jul; 74(1):236-48. PubMed ID: 6429195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutrophil response to Pseudomonas aeruginosa in respiratory infection.
    Ahmed K; Dai TC; Ichinose A; Masaki H; Nagatake T; Matsumoto K
    Microbiol Immunol; 1993; 37(7):523-9. PubMed ID: 7694053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of phagocytosis and host clearance of Pseudomonas aeruginosa.
    Lovewell RR; Patankar YR; Berwin B
    Am J Physiol Lung Cell Mol Physiol; 2014 Apr; 306(7):L591-603. PubMed ID: 24464809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bead-size directed distribution of Pseudomonas aeruginosa results in distinct inflammatory response in a mouse model of chronic lung infection.
    Christophersen LJ; Trøstrup H; Malling Damlund DS; Bjarnsholt T; Thomsen K; Jensen PØ; Hougen HP; Høiby N; Moser C
    Clin Exp Immunol; 2012 Nov; 170(2):222-30. PubMed ID: 23039893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.